Metropolitan Life Insurance Company (MetLife)’s Organon & Co OGN Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,573	Closed	-$184K	–	2375
2023 Q3	$184K	Sell	10,573 -542	-5%	-$11.3K	0.01%	722
2023 Q2	$231K	Sell	11,115 -261	-2%	-$5.67K	0.01%	621
2023 Q1	$268K	Sell	11,376 -3,335	-23%	-$89.5K	0.01%	576
2022 Q4	$411K	Sell	14,711 -429	-3%	-$11K	0.02%	519
2022 Q3	$354K	Sell	15,140 -135	-0.9%	-$4.08K	0.02%	527
2022 Q2	$516K	Sell	15,275 -372	-2%	-$13K	0.02%	494
2022 Q1	$547K	Sell	15,647 -13,335	-46%	-$456K	0.02%	527
2021 Q4	$883K	Sell	28,982 -569	-2%	-$18.5K	0.01%	1051
2021 Q3	$969K	Sell	29,551 -964	-3%	-$30.8K	0.01%	982
2021 Q2	$923K	Buy	+30,515	New	+$1M	0.01%	1076

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $2.98B AUM 22.67% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s OGN Position: Q4 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 10,573 shares — an estimated $184K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $969K in Q3 2021. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

Metropolitan Life Insurance Company (MetLife) reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 10,573 Organon & Co shares in Q4 2023, an estimated $184K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
Metropolitan Life Insurance Company (MetLife)'s Organon & Co position peaked at $969K in Q3 2021.
719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2023, filed 14 Feb 2024.